Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Viability testing for guiding revascularization in ischemic cardiomyopathy.

Current opinion in cardiology·2026
Same authorSame journal

Rebooting blood vessel repair: implications of the SEMA-VR CardioLink-15 trial.

Current opinion in cardiology·2026
Same authorSame journal

Minimally invasive approaches to coronary artery bypass grafting: techniques, current evidence, and future directions.

Current opinion in cardiology·2026
Same author

Coronary physiology and intravascular imaging in surgical and percutaneous revascularization.

Current opinion in cardiology·2026
Same author

Superficial parasternal intercostal plane block with ropivacaine versus placebo for opioid exposure after cardiac surgery (EPOCH CardioLink-10): a multicentre, double-blind, randomised trial.

Lancet regional health. Americas·2026
Same author

Superficial intercostal plane blocks for post-sternotomy pain control rationale and design for the EPOCH CardioLink-10 randomized clinical trial.

Current opinion in cardiology·2026
Same journal

Contemporary medical management of left ventricular assist device patients: integrating sex-specific perspectives.

Current opinion in cardiology·2026
Same journal

An integrative approach to patient selection for mitral transcatheter edge-to-edge repair in secondary mitral regurgitation.

Current opinion in cardiology·2026
Same journal

Advancements in wearable technology for heart failure patients.

Current opinion in cardiology·2026
See all related articles

Related Experiment Video

Updated: May 7, 2026

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
12:17

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

11.9K

Sutureless aortic valves: timing, technique, and evidence.

Shubh K Patel1, Syed M Ali Hassan2, Nitish K Dhingra2

  • 1Temerty Faculty of Medicine, University of Toronto.

Current Opinion in Cardiology
|February 17, 2026
PubMed
Summary
This summary is machine-generated.

Sutureless aortic valve replacement (SuAVR) offers significant benefits, including reduced procedure times and improved outcomes, especially for elderly patients and complex cases. Further research is needed to confirm long-term efficacy and optimize pacemaker avoidance.

Keywords:
aortic stenosisperceval valvesurgical aortic valve replacementsurgical techniquesutureless aortic valve replacement

More Related Videos

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
14:14

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

14.8K
Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

12.3K

Related Experiment Videos

Last Updated: May 7, 2026

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
12:17

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

11.9K
Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
14:14

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

14.8K
Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

12.3K

Area of Science:

  • Cardiovascular Surgery
  • Minimally Invasive Cardiac Surgery
  • Aortic Valve Disease

Background:

  • Sutureless aortic valve replacement (SuAVR) is an evolving technique in cardiac surgery.
  • Understanding its role relative to conventional surgical aortic valve replacement (SAVR) and transcatheter aortic valve implantation (TAVI) is crucial.

Purpose of the Study:

  • To synthesize current evidence on SuAVR, focusing on indications, sizing, technique, outcomes, and complications.
  • To determine where SuAVR offers advantages over SAVR and TAVI.

Main Methods:

  • Review of contemporary studies on SuAVR.
  • Analysis of data regarding operative times, valve performance, and complication rates.
  • Evaluation of mid-term durability and reintervention rates.

Main Results:

  • SuAVR significantly reduces cardiopulmonary bypass and cross-clamp times (25-50%).
  • It yields low gradients, large effective orifice areas, and is beneficial in specific patient groups (elderly, small annuli, redo surgery).
  • Paravalvular leak and permanent pacemaker implantation rates are low (single digits) with optimized techniques.

Conclusions:

  • SuAVR is a valuable surgical option, expanding candidacy for minimally invasive and complex procedures when selected by a Heart Team with standardized protocols.
  • Long-term randomized trials and standardized pacemaker-avoidance strategies are necessary for widespread adoption.